000279169 001__ 279169
000279169 005__ 20250709100935.0
000279169 0247_ $$2doi$$a10.1007/s40120-024-00694-7
000279169 0247_ $$2pmid$$apmid:39738982
000279169 0247_ $$2pmc$$apmc:PMC11762039
000279169 0247_ $$2ISSN$$a2193-6536
000279169 0247_ $$2ISSN$$a2193-8253
000279169 037__ $$aDZNE-2025-00697
000279169 041__ $$aEnglish
000279169 082__ $$a610
000279169 1001_ $$0P:(DE-2719)9002138$$aBuchholz, Maresa$$b0$$eFirst author
000279169 245__ $$aHealth-Related Quality of Life in Patients with Friedreich Ataxia Using Mobility Assistive Technologies: Limited Fit of the EQ-5D-3L Mobility Dimension.
000279169 260__ $$aHeidelberg [u.a.]$$bSpringer$$c2025
000279169 3367_ $$2DRIVER$$aarticle
000279169 3367_ $$2DataCite$$aOutput Types/Journal article
000279169 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1751966055_3174
000279169 3367_ $$2BibTeX$$aARTICLE
000279169 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000279169 3367_ $$00$$2EndNote$$aJournal Article
000279169 520__ $$aFriedreich Ataxia (FA) is a multisystem neurodegenerative disease. Affected individuals rely on mobility assistive technologies (MAT) (e.g. wheelchairs) and require long-term treatments and care. To analyse the patients' health-related quality of life (HRQoL), the EuroQol 5 Dimension 3 Level survey (EQ-5D-3L)-a widely used and recommended generic measure-is used in clinical and in health economic studies. Concerns about using the instrument in mobility-impaired individuals who might have difficulties finding appropriate response options for mobility-related items led us to investigate how the 3L dimensions perform in patients with FA using or not using MAT.Using longitudinal data from 607 patients with FA of the EFACTS study (from baseline to the 3-year follow-up), we analysed the acceptability, distribution properties, validity, and responsiveness of the EQ-5D-3L, focusing on the mobility item. Analyses were stratified for patients without and with different MAT-usage.We identified that n = 177 patients used no MAT, n = 299 a wheelchair and n = 131 walking aids. The mobility item non-response was highest in wheelchair users (6.8%) and lowest in patients without MAT. Walking aid users showed the least variability, all selecting the mid-response option 'some problems' for mobility. The mobility item correlated moderately with disease severity (rsp = 0.35) and the activities of daily living scale (rsp = 0.36) in wheelchair users. No correlation exists for walking aid users. The strongest health changes occurred for wheelchair users, the weakest for walking aid users. The mobility dimensions showed the highest amount of no changes.The EQ-5D-3L's mobility item has limitations in MAT users, particularly in walking aid users, due to a tendency towards mid-responses. These limitations may affect the efficacy and (cost)effectiveness conclusions drawn from interventions and clinical trials with mobility-impaired individuals. Further research is needed to explore the understanding and interpretation of responses of the EQ-5D in patients with FA with mobility support.ClinicalTrials.gov identifier NCT02069509.
000279169 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000279169 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000279169 650_7 $$2Other$$aEQ-5D-3L
000279169 650_7 $$2Other$$aFriedreich Ataxia
000279169 650_7 $$2Other$$aHealth-related quality of life
000279169 650_7 $$2Other$$aMobility assistive technology
000279169 7001_ $$0P:(DE-2719)9002113$$aPfaff, Michelle$$b1$$udzne
000279169 7001_ $$0P:(DE-2719)9003158$$aIskandar, Audrey$$b2$$udzne
000279169 7001_ $$aReetz, Kathrin$$b3
000279169 7001_ $$aSchulz, Jörg B$$b4
000279169 7001_ $$0P:(DE-2719)9001510$$aGrobe-Einsler, Marcus$$b5$$udzne
000279169 7001_ $$0P:(DE-2719)2810314$$aKlockgether, Thomas$$b6$$udzne
000279169 7001_ $$0P:(DE-2719)2810763$$aMichalowsky, Bernhard$$b7$$eLast author$$udzne
000279169 7001_ $$aGroup, EFACTS Study$$b8$$eCollaboration Author
000279169 7001_ $$aBoesch, Sylvia$$b9$$eContributor
000279169 7001_ $$aNachbauer, Wolfgang$$b10$$eContributor
000279169 7001_ $$aEigentler, Andreas$$b11$$eContributor
000279169 7001_ $$aIndelicato, Elisabetta$$b12$$eContributor
000279169 7001_ $$aAmprosi, Matthias$$b13$$eContributor
000279169 7001_ $$aRai, Myriam$$b14$$eContributor
000279169 7001_ $$aPandolfo, Massimo$$b15$$eContributor
000279169 7001_ $$aMariotti, Caterina$$b16$$eContributor
000279169 7001_ $$aNanetti, Lorenzo$$b17$$eContributor
000279169 7001_ $$aGellera, Cinzia$$b18$$eContributor
000279169 7001_ $$aMongelli, Alessia$$b19$$eContributor
000279169 7001_ $$aCastaldo, Anna$$b20$$eContributor
000279169 7001_ $$aFichera, Mario$$b21$$eContributor
000279169 7001_ $$aBertini, Enrico$$b22$$eContributor
000279169 7001_ $$aVasco, Gessica$$b23$$eContributor
000279169 7001_ $$aDurr, Alexandra$$b24$$eContributor
000279169 7001_ $$aEwenczyk, Claire$$b25$$eContributor
000279169 7001_ $$aBiet, Marie$$b26$$eContributor
000279169 7001_ $$aMonin, Marie Lorraine$$b27$$eContributor
000279169 7001_ $$aHoltbernd, Florian$$b28$$eContributor
000279169 7001_ $$aBrcina, Nikolina$$b29$$eContributor
000279169 7001_ $$aHohenfeld, Christian$$b30$$eContributor
000279169 7001_ $$aDidszun, Claire$$b31$$eContributor
000279169 7001_ $$aDogan, Imis$$b32$$eContributor
000279169 7001_ $$0P:(DE-2719)2811662$$aGiordano, Ilaria$$b33$$eContributor$$udzne
000279169 7001_ $$0P:(DE-2719)2810704$$aKlopstock, Thomas$$b34$$eContributor$$udzne
000279169 7001_ $$aStendel, Claudia$$b35$$eContributor
000279169 7001_ $$aRadelfahr, Florentine$$b36$$eContributor
000279169 7001_ $$0P:(DE-2719)9003293$$aBischoff, Almut$$b37$$eContributor$$udzne
000279169 7001_ $$0P:(DE-2719)2810795$$aSchöls, Ludger$$b38$$eContributor$$udzne
000279169 7001_ $$0P:(DE-2719)2813263$$aHayer, Stefanie$$b39$$eContributor$$udzne
000279169 7001_ $$aKoutsis, Georgios$$b40$$eContributor
000279169 7001_ $$aBreza, Marianthi$$b41$$eContributor
000279169 7001_ $$aPalau, Francesc$$b42$$eContributor
000279169 7001_ $$aO'Callaghan, Mar$$b43$$eContributor
000279169 7001_ $$ade Rivera Garrido, Francisco Javier Rodríguez$$b44$$eContributor
000279169 7001_ $$aRummey, Christian$$b45$$eContributor
000279169 7001_ $$aGiunti, Paola$$b46$$eContributor
000279169 7001_ $$aParkinson, Michael H$$b47$$eContributor
000279169 7001_ $$aThomas-Black, Gilbert$$b48$$eContributor
000279169 7001_ $$aManso, Katarina$$b49$$eContributor
000279169 7001_ $$aSolanky, Nita$$b50$$eContributor
000279169 7001_ $$aLabrum, Robyn$$b51$$eContributor
000279169 773__ $$0PERI:(DE-600)2682228-3$$a10.1007/s40120-024-00694-7$$gVol. 14, no. 1, p. 379 - 398$$n1$$p379 - 398$$tNeurology and Therapy$$v14$$x2193-6536$$y2025
000279169 8564_ $$uhttps://pub.dzne.de/record/279169/files/DZNE-2025-00697%20SUP.pdf
000279169 8564_ $$uhttps://pub.dzne.de/record/279169/files/DZNE-2025-00697.pdf$$yOpenAccess
000279169 8564_ $$uhttps://pub.dzne.de/record/279169/files/DZNE-2025-00697%20SUP.pdf?subformat=pdfa$$xpdfa
000279169 8564_ $$uhttps://pub.dzne.de/record/279169/files/DZNE-2025-00697.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000279169 909CO $$ooai:pub.dzne.de:279169$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000279169 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002138$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000279169 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002113$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000279169 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9003158$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000279169 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001510$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000279169 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810314$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000279169 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810763$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b7$$kDZNE
000279169 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2811662$$aExternal Institute$$b33$$kExtern
000279169 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2810704$$aExternal Institute$$b34$$kExtern
000279169 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9003293$$aExternal Institute$$b37$$kExtern
000279169 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2810795$$aExternal Institute$$b38$$kExtern
000279169 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2813263$$aExternal Institute$$b39$$kExtern
000279169 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000279169 9141_ $$y2025
000279169 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-18
000279169 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-18
000279169 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000279169 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-18
000279169 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEUROL THER : 2022$$d2024-12-18
000279169 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:42:53Z
000279169 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:42:53Z
000279169 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-18
000279169 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-18
000279169 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-18
000279169 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-18
000279169 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000279169 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-18
000279169 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-18
000279169 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-18
000279169 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-18
000279169 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-18
000279169 9201_ $$0I:(DE-2719)5000067$$kAG Michalowsky$$lPatient-Reported Outcomes and Health Economics Research$$x0
000279169 9201_ $$0I:(DE-2719)1510800$$kAG Thyrian$$lInterventional Health Care Research (IHCR)$$x1
000279169 9201_ $$0I:(DE-2719)1510600$$kAG Hoffmann$$lTranslational Health Care Research$$x2
000279169 9201_ $$0I:(DE-2719)1011001$$kClinical Research (Bonn)$$lClinical Research Coordination$$x3
000279169 9201_ $$0I:(DE-2719)1011101$$kPatient Studies (Bonn)$$lPatient Studies (Bonn)$$x4
000279169 980__ $$ajournal
000279169 980__ $$aVDB
000279169 980__ $$aUNRESTRICTED
000279169 980__ $$aI:(DE-2719)5000067
000279169 980__ $$aI:(DE-2719)1510800
000279169 980__ $$aI:(DE-2719)1510600
000279169 980__ $$aI:(DE-2719)1011001
000279169 980__ $$aI:(DE-2719)1011101
000279169 9801_ $$aFullTexts